Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- DW5421APhase 31 trial
Daewon Pharmaceutical Co., Ltd. · Primary Hypercholesterolemia, Mixed Dyslipidemia
- DW5421BPhase 31 trial
Daewon Pharmaceutical Co., Ltd. · Primary Hypercholesterolemia, Mixed Dyslipidemia
- DWC202301Phase 31 trial
Daewoong Pharmaceutical Co. LTD. · Helicobacter Pylori Infection, Helicobacter Pylori Infected Patients, Helicobacter Pylori Infected Subjects
- DWC202313Phase 31 trial
Daewoong Pharmaceutical Co. LTD. · Essential Hypertension
- DWC202404Phase 31 trial
Daewoong Pharmaceutical Co. LTD. · Hypertension, Essential Hypertension
- DWC202405Phase 31 trial
Daewoong Pharmaceutical Co. LTD. · Essential Hypertension
- DWC202517Phase 31 trial
Daewoong Pharmaceutical Co. LTD. · Healed Erosive Esophagitis
- DWC202518Phase 31 trial
Daewoong Pharmaceutical Co. LTD. · T2DM (Type 2 Diabetes Mellitus)
- EA-230hourPhase 31 trial
EBI Anti Sepsis BV · Coronary Artery Disease (CAD), Coronary Artery Bypass Graft Surgery(CABG)
- ELA026Phase 31 trial
Electra Therapeutics Inc. · Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
- ElenestinibBLU-263Phase 31 trial
Blueprint Medicines Corporation · Indolent Systemic Mastocytosis, Smoldering Systemic Mastocytosis
- elsunersenPhase 31 trial
Praxis Precision Medicines · Epileptic Encephalopathy, SCN2A Encephalopathy
- ELVN-001Phase 31 trial
Enliven Therapeutics · Chronic Myeloid Leukemia (CML), Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive, Chronic Phase Chronic Myeloid Leukemia, BCR::ABL1 Positive CML
- EU-authorized NivolumabPhase 31 trial
Amgen · Melanoma
- Exa-celPhase 31 trial
Vertex Pharmaceuticals · Sickle Cell Disease, Hematological Diseases, Hemoglobinopathies
- EXV-801deramciclanePhase 31 trial
Exciva GmbH · Agitation Associated With Alzheimer's Disease Dementia
- EXV-802Phase 31 trial
Exciva GmbH · Agitation Associated With Alzheimer's Disease Dementia
- F027Phase 31 trial
Shandong New Time Pharmaceutical Co., LTD · Type 2 Diabetes (T2DM)
- F520Phase 31 trial
Shandong New Time Pharmaceutical Co., LTD · Cancer of Unknown Primary Site
- FDA-licensed NivolumabPhase 31 trial
Amgen · Melanoma
- FDA018-ADCPhase 31 trial
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · Triple Negative Breast Cancer
- FDC laroprovstatPhase 31 trial
AstraZeneca · Hypercholesterolemia
- FDY-5301Phase 31 trial
Faraday Pharmaceuticals, Inc. · Acute Myocardial Infarction, STEMI, Percutaneous Coronary Revascularization
- FE 999049Rekovelle, Follitropin DeltaPhase 31 trial
Ferring Pharmaceuticals · Infertility, Female
- FHND9041Phase 31 trial
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. · Non Small Cell Lung Cancer
- FiclatuzumabAV-299Phase 31 trial
AVEO Pharmaceuticals, Inc. · Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
- FimasartanPhase 31 trial
Boryung Pharmaceutical Co., Ltd · Essential Hypertension
- Fixed of PertuzumabPhase 31 trial
Roche (Genentech) · Early Breast Cancer, Locally Advanced Breast Cancer, Inflammatory Breast Cancer
- FlumatinibPhase 31 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Myeloid Leukemia
- Fluoride-free toothpaste in a Dical basePhase 31 trial
Colgate Palmolive · Remineralization, Enamel Lesions, Enamel Subsurface Lesion
- FRSW117Recombinant human coagulation factor Ⅷ-Fc fusion proteinPhase 31 trial
Hangzhou Gensciences Biopharmaceutical Co., Ltd. · Severe Hemophilia A
- FuzuloparibPhase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- GB06Phase 31 trial
Kexing Biopharm Co., Ltd. · Growth Hormone Deficiency (GHD), Growth Hormone Deficiency in Children, Growth Hormone Deficiency, Pediatric
- GB491Phase 31 trial
Genor Biopharma Co., Ltd. · Breast Cancer
- GC5103Undiluted .-Hepabig inj, Diluted .-Hepabig injPhase 31 trial
GC Biopharma Corp · Hepatitis B
- GC5107GCC 10% IGIVPhase 31 trial
GC Biopharma Corp · Primary Immune Deficiency
- GLSI-100Phase 31 trial
Greenwich LifeSciences, Inc. · Breast Cancer
- GME751Phase 31 trial
Novartis · Metastatic NSCLC
- GNR-055GNR-055 1.0-2.0Phase 31 trial
AO GENERIUM · Mucopolysaccharidosis Type II, Metabolic Diseases
- GNR-068Phase 31 trial
AO GENERIUM · Plaque Psoriasis
- GNR-086Phase 31 trial
AO GENERIUM · Still's Disease Adult Onset
- GQ1005Phase 31 trial
GeneQuantum Healthcare (Suzhou) Co., Ltd. · HER2-positive Breast Cancer
- GS101Phase 31 trial
Jiangsu Genscend Biopharmaceutical Co., Ltd · Atopic Dermatitis (AD)
- GTX-104Phase 31 trial
Grace Therapeutics Inc. · Aneurysmal Subarachnoid Hemorrhage (aSAH)
- HC-1119Phase 31 trial
Hinova Pharmaceuticals Inc. · MCRPC
- HCP1004Phase 31 trial
Hanmi Pharmaceutical Company Limited · Chronic Low-back Pain
- HCP1803-4Phase 31 trial
Hanmi Pharmaceutical Company Limited · Hypertension
- HDM1702Phase 31 trial
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Obesity Control
- Hemay022Phase 31 trial
Tianjin Hemay Pharmaceutical Co., Ltd · Breast Cancer
- HGP1201Phase 31 trial
Hanmi Pharmaceutical Company Limited · Erectile Dysfunction
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.